Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endoscopic Pancreatic Duct Stenting in Early Acute Pancreatitis
NCT07093996Not yet recruiting
- Sponsor
- Almazov National Medical Research Centre
- Start
- Sep 2025
- Primary completion
- Dec 2026
- Countries
- 2
01
Overview
Randomised, open-label trial (2 arms), sponsored by Almazov National Medical Research Centre. Primary endpoint: Mortality rate at 3 months. Planned start Sep 2025; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07093996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07093996.